BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10392410)

  • 1. Ethnic differences in the neuroleptic treatment of schizophrenia.
    Ruiz P; Varner RV; Small DR; Johnson BA
    Psychiatr Q; 1999; 70(2):163-72. PubMed ID: 10392410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excessive antipsychotic dosing in 2 U.S. State hospitals.
    Diaz FJ; De Leon J
    J Clin Psychiatry; 2002 Nov; 63(11):998-1003. PubMed ID: 12444813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Black and white patients response to antidepressant treatment for major depression.
    Varner RV; Ruiz P; Small DR
    Psychiatr Q; 1998; 69(2):117-25. PubMed ID: 9627929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A transcultural study of psychopharmacotherapy for schizophrenia of neuroleptic treatment between Tokyo and Bali.
    Kurihara T; Yagi G; Reverger R; Kawai N; Inada T
    Psychiatry Clin Neurosci; 1998 Dec; 52 Suppl():S188-9. PubMed ID: 9895143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of ethnicity and gender to schizophrenia and pharmacology of neuroleptics.
    Jeste DV; Lindamer LA; Evans J; Lacro JP
    Psychopharmacol Bull; 1996; 32(2):243-51. PubMed ID: 8783894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation of ethnic and gender differences in the pharmacodynamics of haloperidol.
    Zhang-Wong J; Beiser M; Zipursky RB; Bean G
    Psychiatry Res; 1998 Dec; 81(3):333-9. PubMed ID: 9925184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic dosing in Hispanic and Asian Inpatients with schizophrenia.
    Collazo Y; Tam R; Sramek J; Herrera J
    Mt Sinai J Med; 1996; 63(5-6):310-3. PubMed ID: 8898533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnic variation in symptoms and response to risperidone in youths with schizophrenia-spectrum disorders.
    Patel NC; Crismon ML; Shafer A; De Leon A; Lopez M; Lane DC
    Soc Psychiatry Psychiatr Epidemiol; 2006 May; 41(5):341-6. PubMed ID: 16467950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial disparities in antipsychotic prescription patterns for patients with schizophrenia.
    Kuno E; Rothbard AB
    Am J Psychiatry; 2002 Apr; 159(4):567-72. PubMed ID: 11925294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic and anticholinergic drug use in Chinese patients with schizophrenia resident in a state psychiatric hospital in Singapore.
    Chong SA; Sachdev P; Mahendran R; Chua HC
    Aust N Z J Psychiatry; 2000 Dec; 34(6):988-91. PubMed ID: 11127630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethnic differences in use of antipsychotic medication among Texas medicaid clients with schizophrenia.
    Opolka JL; Rascati KL; Brown CM; Barner JC; Johnsrud MT; Gibson PJ
    J Clin Psychiatry; 2003 Jun; 64(6):635-9. PubMed ID: 12823076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial disparity in the use of atypical antipsychotic medications among veterans.
    Copeland LA; Zeber JE; Valenstein M; Blow FC
    Am J Psychiatry; 2003 Oct; 160(10):1817-22. PubMed ID: 14514496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia.
    Fijal BA; Kinon BJ; Kapur S; Stauffer VL; Conley RR; Jamal HH; Kane JM; Witte MM; Houston JP
    Pharmacogenomics J; 2009 Oct; 9(5):311-8. PubMed ID: 19451915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative doses and costs of antipsychotic medication.
    Davis JM
    Arch Gen Psychiatry; 1976 Jul; 33(7):858-61. PubMed ID: 8024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who receives long-acting antipsychotic medications?
    Glazer WM
    Psychiatr Serv; 2007 Apr; 58(4):437. PubMed ID: 17412839
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neuroleptic malignant syndrome. Case reports].
    Berardi D; Troia M; Veronesi L; Ferrari G
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroleptic treatment by the established psychiatrist. A report of experiences].
    Haberfellner EM; Rittmannsberger H
    Psychiatr Prax; 1998 Nov; 25(6):284-5. PubMed ID: 9885840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment-resistant schizophrenia--the role of clozapine.
    Meltzer HY
    Curr Med Res Opin; 1997; 14(1):1-20. PubMed ID: 9524789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Pilot Study of Cultural/Racial Differences in Patient Perspectives on Long-Acting Injectable Antipsychotics for the Treatment of Schizophrenia.
    Potkin SG; Bera R; Eramo A; Lau G
    Clin Schizophr Relat Psychoses; 2017; 10(4):211-221. PubMed ID: 24846880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.